These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31167810)

  • 1. ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease.
    Marchi C; Adorni MP; Caffarra P; Ronda N; Spallazzi M; Barocco F; Galimberti D; Bernini F; Zimetti F
    J Lipid Res; 2019 Aug; 60(8):1449-1456. PubMed ID: 31167810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease.
    Yassine HN; Feng Q; Chiang J; Petrosspour LM; Fonteh AN; Chui HC; Harrington MG
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
    He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
    Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ATP-binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms.
    Yazdi MK; Alavi MS; Roohbakhsh A
    Basic Clin Pharmacol Toxicol; 2024 Apr; 134(4):423-438. PubMed ID: 38275217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's disease.
    Ko YA; Billheimer JT; Lyssenko NN; Kueider-Paisley A; Wolk DA; Arnold SE; Leung YY; Shaw LM; Trojanowski JQ; Kaddurah-Daouk RF; Kling MA; Rader DJ
    Alzheimers Res Ther; 2022 Dec; 14(1):194. PubMed ID: 36572909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma.
    Adorni MP; Biolo M; Zimetti F; Palumbo M; Ronda N; Scarinzi P; Simioni P; Lupo MG; Ferri N; Previato L; Bernini F; Zambon A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease.
    Cipollari E; Szapary HJ; Picataggi A; Billheimer JT; Lyssenko CA; Ying GS; Shaw LM; Kling MA; Kaddurah-Daouk R; Rader DJ; Praticò D; Lyssenko NN;
    J Alzheimers Dis; 2020; 74(2):563-578. PubMed ID: 32065798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
    J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier.
    Kober AC; Manavalan APC; Tam-Amersdorfer C; Holmér A; Saeed A; Fanaee-Danesh E; Zandl M; Albrecher NM; Björkhem I; Kostner GM; Dahlbäck B; Panzenboeck U
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):573-588. PubMed ID: 28315462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy.
    Kockx M; Roberts L; Wang J; Tran C; Brown MA; Kritharides L
    Atheroscler Plus; 2022 Apr; 48():12-19. PubMed ID: 36644562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1.
    Hou L; Tang S; Wu BJ; Ong KL; Westerterp M; Barter PJ; Cochran BJ; Tabet F; Rye KA
    FASEB J; 2019 Jul; 33(7):8479-8489. PubMed ID: 30970222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.
    Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
    J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels.
    Katzov H; Bennet AM; Höglund K; Wiman B; Lütjohann D; Brookes AJ; Andreasen N; Blennow K; De Faire U; Prince JA
    J Hum Genet; 2006; 51(3):171-179. PubMed ID: 16372134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Density Lipoprotein Function Is Reduced in Patients Affected by Genetic or Idiopathic Hypogonadism.
    Adorni MP; Zimetti F; Cangiano B; Vezzoli V; Bernini F; Caruso D; Corsini A; Sirtori CR; Cariboni A; Bonomi M; Ruscica M
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3097-3107. PubMed ID: 30835274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation.
    Kim WS; Rahmanto AS; Kamili A; Rye KA; Guillemin GJ; Gelissen IC; Jessup W; Hill AF; Garner B
    J Biol Chem; 2007 Feb; 282(5):2851-61. PubMed ID: 17121837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Asztalos BF; Hauser TH; Goldfine AB; Welty FK; Horvath KV; Schaefer EJ
    Atherosclerosis; 2022 Mar; 345():1-6. PubMed ID: 35183903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
    Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.